This is what I'm gathering.......
*Dr. Chen on staff and completing Herpes mouse study.
General public lead to believe (rightly or wrongly) mouse study results would be forthcoming, within weeks. (I'm not a scientist, but shouldn't this take months? Maybe this was our fault.)
*Phanual Persuits Inc. on board as a distributor of Herpes products.
*PR post of Phanuel agreement removed from website and somewhat poor Phanuel bedside manner when questioned.
*Agreement with China and India rights but no amount of Phanual dollars mentioned.
*Talk of new investors with "big money" yet no PR informing us of such.
*Insiders buying (Skolnick, Vasquez, Wunderlich) and the public selling with MM's seemingly the short term winners.
*Their website is down and they don't return calls. Then we learn the fee info. went to someone no longer working there and calls were interrupted while they were moving offices.
*Stock price all over the board while no PR to help control skiddishness..........Confusion.........
We have Dr. Stein working at Albert Einstein and Dr. Duvik working at MD Anderson both on/advising our Boards and working with our technology. They must see something........
Could we have seven extreemely bright scientists and with breakthrough technology yet unskilled in public realations or releases?
I don't feel this ride is over. I'm betting the technology will succeed, we will get our products refined and to market(BioZone) and at worst be in position for purchase by a big Pharma within 18-24 months if that is the best option.
I see growing pains, learning curves and patience.
I'm waiting this one out. Any thoughts welcome.....
AI
Market Data 
Markets 
